What's New
Front Page
Passage Bio Announces Hopeful Initial Data from Phase 1/2 Clinical Trial
Passage Bio released promising preliminary results from its phase 1/2 clinical trial evaluating an experimental treatment for…
Tips & Advice: Navigating Apathy in FTD
A hallmark symptom of FTD, apathy can be particularly hard to deal with for persons diagnosed, care…
Advancing Hope: AFTD hosts FTD Social at the Society for Neuroscience Annual Meeting
The Society for Neuroscience (SfN), with nearly 35,000 members in 95 countries, is the world’s largest professional…
Editor Shares How Basketball Helps Him Bond with Friend Who Has PPA
Retired managing editor Lonny Cain of The Times (Ottawa, Ill.) shared in a recent article how basketball…
“We’re Just Regular People with an Illness,” Dementia Advocate with FTD Writes in Essay
In an essay published by Inside Ageing, Bobby Redman, a retired behavioral psychologist living with FTD, discusses…
Volunteer Update: Hosting a Meet & Greet Event
By hosting a Meet & Greet on behalf of AFTD, volunteers can bring together people affected by…
Advancing Hope: AFTD Manager of Genetic Initiatives Attends National Society of Counselors Annual Education Conference
AFTD’ Manager of Genetic Initiatives Kim Jenny, MS, LCGC, attended the 2023 National Society of Genetic Counselors…
AFTD Volunteer Highlights Differences Between FTD and Alzheimer’s in Newspaper Article
AFTD volunteer Wanda Smith highlighted the differences between FTD and Alzheimer’s disease in a recent article published…
AFTD Webinar: Approaching a Cure — FTD Genetics and Clinical Trials
The landscape of FTD research has evolved tremendously over the last decade. FTD-causing genetic variants, and the…
Dear HelpLine: Connecting During Facility Visits
Dear HelpLine, My mom has FTD and lives in a facility, and I am struggling to find…
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)